Maryland, 23 Dec 2024: The FDA has approved the first generic form of liraglutide (Victoza), a once-daily injectable for improving glycemic control in patients ages 10 and older with type 2 diabetes, used as an adjunct to diet and exercise.

 

This is the seco......
View Details

Related News

• Karnataka HC directs government not to act against firms producing nutraceuticals in drug-licensed units until next hearing (25-12-2024)

---

• DoP reprimands AbbVie Healthcare for unethical marketing practices (25-12-2024)

---

• 3 held with Rs 25 lakh regulated drugs in Mango Jamshedpur (25-12-2024)

---

• NCB Hyderabad dismantles an illicit Alprazolam unit in Telangana, 32.5 kg seized (25-12-2024)

---

• TSMC files 400 FIRs against quacks in Telangana (24-12-2024)

---

• District Collector issued instructions regarding Misused Banned Narcotic Drugs (24-12-2024)

---

• Dabur takes Patanjali to Delhi High Court over disparaging Chyawanprash ad (24-12-2024)

---

• PMO steps in, asks health ministry to act against misleading adverts (24-12-2024)

---

• AIIMS, Delhi developing low cost adaptive cellular therapy for treatment of multiple myeloma (24-12-2024)

---

• US FDA approves Mesoblast's first-of-its-kind cell therapy (24-12-2024)

---